Since the beginning of 2018 there has been a cloud of uncertainty surrounding the legal cannabis industry in the United States. In January, Attorney General Jeff Session redacted the Cole Memorandum, an Obama era policy that withheld the federal government from interfering and prosecuting legal recreational and medical cannabis states.
Luckily a number of bipartisan Congress members have now recently become pro-cannabis politicians and are taking a firm stand on protecting states that have passed legally passed cannabis legislation. Just last week, Congress renewed protections for medical and recreational states with a surprise vote. The Rohrabacher-Farr amendment will withhold any federally funding to interfere with any legal statewide cannabis programs. These protections will now be upheld through 2019. The amendment will now be voted on by the Senate Appropriations Committee which has a history of voting in favor of the medical cannabis industry.
“Today marks a victory for medical marijuana programs and a loss for Attorney General Jeff Sessions. Passage of this amendment through regular order in the appropriations committee represents another big step in the normalization of state level marijuana reform in the Congress of the United States,” NORML Political Director Justin Strekal said in a statement.
You may be interested
Cash Crop Today Interview with David Boissinot from TrimproEditor - October 23, 2018
Trimpro developes and manufactures top of the line, full service, trimming machines in Canada which can be shipped to growers throughout the world. The following is a…
OTC Markets Group Welcomes TerrAscend Corp. to OTCQXJaelynn Offerman - October 22, 2018
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…
Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic BeveragesJaelynn Offerman - October 22, 2018
Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…